![](/img/cover-not-exists.png)
Interleukin (IL)-18 may enhance Th1 response in early cancer but aggravate malignant disease in its later stages
Zahra MojtahediVolume:
65
Year:
2005
Language:
english
DOI:
10.1016/j.mehy.2005.05.026
File:
PDF, 37 KB
english, 2005